BioXcel Therapeutics (BX20.F) Q4 2024 Earnings

Nov 14Confirmed
Q4 2024
-7.68
-6.74
-5.8
-4.86

Details

Expected EPS
-7.681500597099999
Actual EPS
-4.8622592
Surprise EPS
2.82
Surprise Percent
+36.7%

Description

⁨BioXcel Therapeutics⁩ (⁦BX20.F⁩) has reported earnings of ⁦-4.8622592⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts